BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9869018)

  • 1. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
    Omboni S; Zanchetti A
    J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability.
    Xu M; Wu Y; Wang H; Xu X; Zhao S; Zhang M; Jin H; Yan J; Wang B; Gong J; Lu X; Peng J; Dai Q
    Curr Med Res Opin; 2016 Oct; 32(sup2):43-52. PubMed ID: 27779454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lercanidipine vs lacidipine in isolated systolic hypertension.
    Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
    J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension.
    Barbagallo M; Barbagallo Sangiorgi G
    Aging (Milano); 2000 Oct; 12(5):375-9. PubMed ID: 11126524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference between office and ambulatory blood pressure and response to antihypertensive treatment.
    Parati G; Omboni S; Mancia G
    J Hypertens; 1996 Jun; 14(6):791-7. PubMed ID: 8793703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
    Cao TS; Huynh VM; Tran VH
    Curr Med Res Opin; 2015 Jan; 31(1):163-70. PubMed ID: 25425058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
    James IG; Jones A; Davies P
    J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension.
    Parati G; Omboni S; Rizzoni D; Agabiti-Rosei E; Mancia G
    J Hypertens; 1998 Nov; 16(11):1685-91. PubMed ID: 9856370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
    Palatini P; Malacco E; Di SS; Carretta R; Dorigatti F; Bertocchi F; Mann J
    Eur J Clin Pharmacol; 2002 Jan; 57(11):765-70. PubMed ID: 11868797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lercanidipine hydrochloride versus felodipine sustained-release for mild-to-moderate hypertension: a multi-center, randomized clinical trial.
    Wu Y; Xu M; Wang H; Xu X; Zhao S; Zhang M; Jin H; Yan J; Wang B; Gong J; Lu X; Peng J; Dai Q
    Curr Med Res Opin; 2015 Jan; 31(1):171-6. PubMed ID: 25425015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
    Ghamami N; Chiang SH; Dormuth C; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A; Omboni S
    Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.